首页> 外文会议>Optical Methods for Tumor Treatment and Early Diagnosis: Mechanisms and Techniques >Effectiveness of porphyrin-like compounds in photodynamic damage of atherosclerotic plaque
【24h】

Effectiveness of porphyrin-like compounds in photodynamic damage of atherosclerotic plaque

机译:卟啉样化合物在动脉粥样硬化斑块光动力损伤中的作用

获取原文
获取原文并翻译 | 示例

摘要

Abstract: Porphyrin-like compounds such as tetra-(4 sulfonatophenyl) porphine (TSPP), chlorin-e$-6$/ derivative (CED) and tetrasulfophthalocyanin (TSPC) are photosensitizing agents that absorbed light at 630 nm, 657 nm and 625 nm, respectively, and bind preferentially to atherosclerotic plaque. Porphyrin-treated human cadaveric aorta was compared with untreated aorta using several techniques: the absorptive spectrophotometry which has demonstrated the distinct absorptive peaks at 630 nm, 657 nm, 625 nm in porphyrin-treated plaque which were absent in untreated normal aorta; the fluorescence microscopy, which has shown that the treated atheroma acquired the characteristic fluorescence of porphyrin under ultraviolet light. Because of the porphyrin's unique property, porphyrin-treated and untreated aorta was exposed to red laser radiation at a wavelength of 632.8 nm. It was found that enhanced photoalteration of porphyrin-treated compared with untreated atheroma. Histologic analysis of the depth of tissue penetration of equal amounts of laser radiation has demonstrated more pronounced photosensitizing effect in TSPC-treated plaque compared with CED-, TSPP-, and untreated plaques. This study demonstrates a potential of tetrasulfophthalocyanin for selective alteration of atheroma by He-Ne laser radiation.!
机译:摘要:卟啉样化合物如四-(4-磺酰基苯基)卟啉(TSPP),二氢卟酚-e $ -6 $ /衍生物(CED)和四磺酞菁(TSPC)是在630 nm,657 nm和625处吸收光的光敏剂。分别与nm和优先结合到动脉粥样硬化斑块。用几种技术比较了用卟啉处理的人尸体主动脉和未处理的主动脉:吸收分光光度法已证明在用卟啉处理的斑块中在630 nm,657 nm,625 nm处有明显的吸收峰,而在未经处理的正常主动脉中则没有。荧光显微镜显示,治疗后的动脉粥样硬化在紫外光下获得了卟啉的特征荧光。由于卟啉的独特性质,经卟啉处理的主动脉和未经处理的主动脉都暴露于波长为632.8 nm的红色激光辐射中。发现与未经处理的动脉粥样硬化相比,经卟啉处理的光增高作用增强。对等量激光辐射的组织穿透深度的组织学分析表明,与CED,TSPP和未处理的斑块相比,TSPC处理的斑块具有更明显的光敏作用。这项研究证明了四磺酞菁具有通过He-Ne激光辐射选择性改变动脉粥样硬化的潜力。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号